We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Wins 180-Day Exclusivity for Hyzaar, Cozaar in Appeal
Teva Wins 180-Day Exclusivity for Hyzaar, Cozaar in Appeal
March 16, 2010
Teva Pharmaceutical has successfully appealed a court decision that said the drugmaker had forfeited 180-day exclusivity for its generic versions of Merck
hypertension drugs Hyzaar and Cozaar.